PHYLOGENETIC REVISION OF THE GENUS ARENIVAGA (REHN) (BLATTODEA: CORYDIIDAE), WITH DESCRIPTIONS OF NEW SPECIES, A KEY TO THE MALES, AND AN INVESTIGATION OF ITS ECOLOGICAL NICHE

The cockroach genus Arenivaga is revised. Forty-eight Arenivaga species are recognized with nine previously known species and 39 described as new including the following: A. pagana sp. n., A. grandiscanyonensis sp. n., A. haringtoni sp. n., A. hopkinsorum sp. n., A. umbratilis sp. n., A. tenax sp. n., A. impensa sp. n., A. trypheros sp. n., A. darwini sp. n., A. nalepae sp. n., A. sequoia sp. n., A. mckittrickae sp. n., A. gaiophanes sp. n., A. belli sp. n., A. estelleae sp. n., A. delicata sp. n., A. mortisvallisensis sp. n., A. milleri sp. n., A. pratchetti sp. n., A. gumperzae sp. n., A. rothi sp. n., A. ricei sp. n., A. adamsi sp. n., A. nicklei sp. n., A. akanthikos sp. n., A. moctezuma sp. n., A. paradoxa sp. n., A. apaeninsula sp. n., A. hebardi sp. n., A. dnopheros sp. n., A. aquila sp. n., A. florilega sp. n., A. galeana sp. n., A. gurneyi sp. n., A. pumila sp. n., A. hypogaios sp. n., A. diaphana sp. n., A. nocturna sp. n., A. alichenas sp. n. All species are described or redescribed, major morphological features are illustrated, distributions are characterized, and the biology of the species is reviewed. A neotype series is designated for A. investigata Friauf & Edney. The phylogenetic relationships between 24 species of the Corydiid cockroach genus Arenivaga were investigated using morphological and molecular data. The molecular dataset included the following markers: the nuclear gene histone III (H3), the mitochondrial ribosomal RNA gene 12S (12S), and the mitochondrial cytochrome c oxidase I gene (CO1). The phylogenetic relationships of these 24 species were then explored using three optimality criteria: parsimony, maximum likelihood and Bayesian analyses. The putative sister genus Eremoblatta and more distantly related Blatta orientalis were used as outgroups. A partitioned Bremer analysis was performed to provide some insight into which portions of the data provided the most evolutionary insight into this unusual group of insects. All analyses confirm the genus is monophyletic. Several relationships within the genus are recovered with strong support. Both the parsimony and likelihood estimations fail to provide good resolution along the backbone of the generic tree, whereas the Bayesian estimation resolves most nodes. Most of the strongly supported relationships are reinforced by both geographical distribution and genital morphology. The relative contributions of 23 ecological variables to the niche of the genus Arenivaga were examined. This analysis revealed that more than 95% of their ecological niche could be described by eight variables: soil, isothermality, minimum temperature of the coldest month, mean temperature of the driest quarter, annual precipitation, precipitation of the driest month, precipitation of the wettest quarter and ground cover. These eight variables with respect to their relative contributions to the niche of the genus as a whole as well as the individual niches of 27 species in the genus were then examined. This revealed the similarity of niche composition of most of the species, as well as how varied the niches were of several species. A species dendrogram built from similarity of contribution of the eight variables to niche composition was compared to a phylogeny of the genus, but few similarities in topology were found. This analysis revealed that soil is the most important contributor to these species niches, followed by precipitation of the driest month, and finally, precipitation of the wettest quarter. It also confirmed that the majority of Arenivaga species have niches comprised of similar, but not identical, proportions of as few as four, and as many as eight ecological variables. Currently there is no evidence to support niche conservatism between closely related species, indicating that adapting to new and variable niches is one of the drivers of speciation in this genus

Apes communicate about absent and displaced objects: methodology matters

Displaced reference is the ability to refer to an item that has been moved (displaced) in space and/or time, and has been called one of the true hallmarks of referential communication. Several studies suggest that nonhuman primates have this capability, but a recent experiment concluded that in a specific situation (absent entities) human infants display displaced reference but chimpanzees do not. Here we show that chimpanzees and bonobos of diverse rearing histories are capable of displaced reference to absent and displaced objects. It is likely that some of the conflicting findings from animal cognition studies are due to relatively minor methodological differences, but are compounded by interpretation errors. Comparative studies are of great importance in elucidating the evolution of human cognition, however, greater care must be taken with methodology and interpretation for these studies to accurately reflect species differences

Can genetic markers predict the sporadic form of Alzheimer’s disease? An updated review on genetic peripheral markers

Alzheimer’s disease (AD) is the most common form of dementia that affects millions of individuals worldwide. Although the research over the last decades has provided new insight into AD pathophysiology, there is currently no cure for the disease. AD is often only diagnosed once the symptoms have become prominent, particularly in the late-onset (sporadic) form of AD. Consequently, it is essential to further new avenues for early diagnosis. With recent advances in genomic analysis and a lower cost of use, the exploration of genetic markers alongside RNA molecules can offer a key avenue for early diagnosis. We have here provided a brief overview of potential genetic markers differentially expressed in peripheral tissues in AD cases compared to controls, as well as considering the changes to the dynamics of RNA molecules. By integrating both genotype and RNA changes reported in AD, biomarker profiling can be key for developing reliable AD diagnostic tools

Accuracy of two malaria rapid diagnostic tests (RDTS) for initial diagnosis and treatment monitoring in a high transmission setting in Uganda.

Malaria rapid diagnostic tests (RDTs) may improve fever management in areas without microscopy. We compared the accuracy of histidine-rich protein 2 (HRP2) and Plasmodium lactate dehydrogenase (pLDH)-based RDTs, using expert microscopy as a gold standard, for initial diagnosis, treatment monitoring, and diagnosis of recurrent malaria in a cohort of children followed longitudinally in a high-transmission area in Uganda. For 305 initial fever episodes, sensitivity was 98% for HRP2 and 87% for pLDH, whereas specificity was 55% and 96%, respectively. The HRP2 gave 51% false-positive results on Day 28, whereas pLDH gave no false positives after Day 7. For 59 recurrent fever episodes during follow-up, sensitivity was 100% for HRP2 and 91% for pLDH, whereas specificity was 33% and 100%, respectively. The HRP2-based RDTs are useful for initial diagnosis of malaria caused by superior sensitivity; however, as a result of superior specificity, pLDH-based RDTs are more appropriate to monitor treatment and diagnose recurrent malaria

Short report: Dynamics of Plasmodium falciparum malaria after sub-optimal therapy in Uganda.

We followed parasite genotypes of 75 patients for 42 days after treatment of uncomplicated malaria with chloroquine + sulfadoxine-pyrimethamine in Kampala, Uganda. Infections were complex (mean, 2.88 strains) and followed three patterns: 27% of patients eliminated all strains and remained parasite-free, 48% had a long aparasitemic interval followed by reappearance of original strains after 3-33 days (mean, 9.2 days), and 25% failed to clear original strains and required therapy after 3-35 days (mean, 17 days). These results highlight the complexity of malaria in Africa and have implications for efficacy trials, because missing late reappearances of strains could lead to misclassification of outcomes

Effect of method of administration on longitudinal assessment of quality of life in gynecologic cancer: An exploratory study

BACKGROUND: Longitudinal assessments of quality of life are needed to measure changes over the course of a disease and treatment. Computer versions of quality of life instruments have increased the feasibility of obtaining longitudinal measurements. However, there remain occasions when patients are not able to complete these questionnaires. This study examined whether changes measured using a computer version of the Functional Assessment of Cancer Therapy – General (FACT-G) on two occasions would be obtained if patients completed a paper version on one of the two occasions. METHODS: Gynecologic oncology patients completed a computer version of the FACT-G pre-operatively and at six months. Patients were given the option of using the paper version instead of the computer at either time point. Repeated measures analysis of variance was used. RESULTS: One hundred nineteen patients completed the FACT-G at both time points. Seventy-one (60%) patients used the computer at both visits, 26 (21.8%) used the computer followed by the paper version, 17 (14.3%) used the paper version followed by the computer version, and five patients (4.2%) used the paper version at both visits. Significant effects over time were obtained in the physical, functional, and emotional well-being domains, and in total scores, but there were no effects of method of administration of the questionnaires and no interaction between method of administration and changes over time. CONCLUSIONS: These data indicate that women are responding to the content of the questionnaire and not method of data collection. Although using the same method of administration of instruments over time is desirable, using alternate methods is preferable to forgoing data collection entirely. Large scale studies should be conducted to determine if the multiple methods of data collection that are becoming increasingly available are producing interchangeable information

Review: The Journal of Dramaturgy, volume 21, issue 2

Contents include: Celebrating 25 Years of Review; On African American Dramaturgy One Professional\u27s Personal Response; The Revolution Will Not Be Televised, But Can It Theatricalized?; Tahrir Stories Excerpts From A Verbatim Theatre Project Composed and Performed During the 2011 Egyptian Revolution; Introduction to the review of Burning the House: On Directing and Dramaturgy, by Eugenio Barba; Eugenio Barba\u27s On Directing and Dramaturgy: Burning the House; A Servant of Two or Three or Four or More...Masters, Business Advice for Dramaturgs Working in Virgin Territory; Bryan Doerries\u27s Theater of War, A New Incarnation of an Ancient Ritual. Issue editors: D.J. Hopkins, Sydney Cheek O\u27Donnell, Lauren Beckhttps://soundideas.pugetsound.edu/lmdareview/1042/thumbnail.jp

CD4 T cell activation as a predictor for treatment failure in Ugandans with Plasmodium falciparum malaria.

Host immunity plays an important role in response to antimalarial therapy but is poorly understood. To test whether T cell activation is a risk factor for antimalarial treatment failure, we studied CD4(+) and CD8(+) T cell activation in 31 human immunodeficiency virus-negative Ugandan patients 5-37 years of age who were treated for uncomplicated Plasmodium falciparum malaria. Increased CD4(+) T cell activation, as indicated by co-expression of HLA-DR and CD38, was an independent risk factor for treatment failure (hazard ratio = 2.45, 95% confidence interval = 1.02-5.89, P = 0.05) in multivariate analysis controlling for age, baseline temperature, and pre-treatment parasite density. The results provide insight into the role of cellular immunity in response to antimalarial therapy and underscore the need to investigate the mechanisms behind immune activation

Redefining typhoid diagnosis: what would an improved test need to look like?

INTRODUCTION: Typhoid fever is one of the most common bacterial causes of acute febrile illness in the developing world, with an estimated 10.9 million new cases and 116.8 thousand deaths in 2017. Typhoid point-of-care (POC) diagnostic tests are widely used but have poor sensitivity and specificity, resulting in antibiotic overuse that has led to the emergence and spread of multidrug-resistant strains. With recent advances in typhoid surveillance and detection, this is the ideal time to produce a target product profile (TPP) that guides product development and ensure that a next-generation test meets the needs of users in the resource-limited settings where typhoid is endemic. METHODS: A structured literature review was conducted to develop a draft TPP for a next-generation typhoid diagnostic test with minimal and optimal desired characteristics for 36 test parameters. The TPP was refined using feedback collected from a Delphi survey of key stakeholders in clinical medicine, microbiology, diagnostics and public and global health. RESULTS: A next-generation typhoid diagnostic test should improve patient management through the diagnosis and treatment of infection with acute Salmonella enterica serovars Typhi or Paratyphi with a sensitivity ≥90% and specificity ≥95%. The test would ideally be used at the lowest level of the healthcare system in settings without a reliable power or water supply and provide results in <15 min at a cost of <US$1.00. CONCLUSION: This report outlines the first comprehensive TPP for typhoid fever and is intended to guide the development of a next-generation typhoid diagnostic test. An accurate POC test will reduce the morbidity and mortality of typhoid fever through rapid diagnosis and treatment and will have the greatest impact in reducing antimicrobial resistance if it is combined with diagnostics for other causes of acute febrile illness in a treatment algorithm

Plasmodium falciparum parasites with histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in two endemic regions of Kenya.

Deletions of the Plasmodium falciparum hrp2 and hrp3 genes can affect the performance of HRP2-based malaria rapid diagnostic tests (RDTs). Such deletions have been reported from South America, India and Eritrea. Whether these parasites are widespread in East Africa is unknown. A total of 274 samples from asymptomatic children in Mbita, western Kenya, and 61 genomic  data from Kilifi, eastern Kenya, were available for analysis. PCR-confirmed samples were investigated for the presence of pfhrp2 and pfhrp3 genes. In samples with evidence of deletion, parasite presence was confirmed by amplifying three independent genes. We failed to amplify pfhrp2 from 25 of 131 (19.1%) PCR-confirmed samples. Of these, only 8 (10%) samples were microscopic positive and were classified as pfhrp2-deleted. Eight microscopically-confirmed pfhrp2-deleted samples with intact pfhrp3 locus were positive by HRP2-based RDT. In addition, one PCR-confirmed infection showed a deletion at the pfhrp3 locus. One genomic sample lacked pfhrp2 and one lacked pfhrp3. No sample harbored parasites lacking both genes. Parasites lacking pfhrp2 are present in Kenya, but may be detectable by HRP-based RDT at higher parasitaemia, possibly due to the presence of intact pfhrp3. These findings warrant further systematic study to establish prevalence and diagnostic significance